Synthesis and applications of theranostic oligonucleotides carrying multiple fluorine atoms

Valeriy G Metelev1,2, Alexei A Bogdanov1,3,4

  • 1Laboratory of Molecular Imaging Probes, Department of Radiology, University of Massachusetts Medical School, Worcester MA, USA.

Theranostics
|January 16, 2020
PubMed

Insights

Multifluorinated (MF) groups enhance oligonucleotide (ON) properties for gene therapy. These modifications improve cellular uptake, stability, and delivery, showing potential for novel ON-based therapies.

Area of Science:

  • Oligonucleotide chemistry
  • Medicinal chemistry
  • Molecular biology

Background:

  • Oligonucleotides (ONs) are crucial for modulating gene expression but face challenges in cellular delivery and stability.
  • Current strategies aim to improve ON efficacy through chemical modifications and advanced delivery systems.
  • Developing novel ON derivatives is essential for enhancing their therapeutic potential.

Purpose of the Study:

  • To review the synthesis and properties of oligonucleotide derivatives incorporating multifluorinated (MF) groups.
  • To explore the impact of MF groups on ON physicochemical characteristics and cellular interactions.
  • To assess the potential of MF-modified ONs for improving therapeutic applications.

Main Methods:

  • Review of literature on oligonucleotide synthesis and chemical modification strategies.
  • Analysis of the properties of multifluorinated groups, including hydrophobicity and lipophobicity.
  • Evaluation of evidence regarding the performance of MF-modified ONs in vitro and in vivo.

Main Results:

  • Multifluorinated (MF) groups impart unique hydrophobicity and lipophobicity to oligonucleotides (ONs).
  • These properties modify the interaction of ONs with cells, enhancing cellular uptake and lysosomal escape.
  • MF-modified ONs demonstrate improved stability, target specificity, and delivery efficiency.

Conclusions:

  • Multifluorinated ONs show significant promise for improving the potency and delivery of ON-based therapeutics.
  • MF groups offer a valuable strategy for overcoming key challenges in oligonucleotide drug development.
  • Further research into MF-modified ONs could lead to advanced therapies for various diseases.